CORNERSTONE RESEARCH GROUP INC — Department of Defense SBIR Phase II: DHA191-011

CORNERSTONE RESEARCH GROUP INC — SBIR Phase II award from Department of Defense.

Amount
$1,649,753
Agency
Department of Defense · Defense Health Program
Program / Phase
SBIR · Phase II
Topic
DHA191-011
Solicitation
19.1
NAICS
Place of performance
OH
Period
2022-08-01 → 2023-09-08

Description

CRG completed the first steps toward developing an externally wearable, non-invasive, battery-operated device capable of providing analgesia equivalent to pharmacological peripheral ring nerve blocks by manipulating nervous system activity with magnetic fields. The approach involves optimizing magnetic coils for the transmission of specific waveforms of electrical stimulation to nociceptive nerve fibers. This device will enable point-of-injury analgesia for warfighters and provide an alternative to pharmacological analgesia. In Phase I, CRG demonstrated the feasibility of this device by showing non-contact transmission of analgesic waveforms using fabricated coils in a laboratory setting. These results correlated strongly with electromagnetic modeling efforts.